Asset 1

Concordance Study Services

Fast-track concordance studies with our reliable biomarker services and Health Institution status.

Concordance studies are critical to successfully complete and select appropriate biomarkers for clinical trials and diagnostic development. Discovery has built a robust solution integrating the largest commercial biorepository with expert
multi-omic services to accelerate concordance studies cost-effectively.

Advantages of Discovery’s Concordance Study Services

Clinical Specimens

Direct access to the world’s largest commercial biorepository.


Decades of experience developing and validating companion diagnostics for leading biotech and pharma clients.


A technology agnostic approach to enable an unbiased selection of the most suitable platforms.

Compliance & Quality

Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support concurrent clinical trials and regulatory submissions.

Global Harmonization

Global standardization and harmonization of IHC assays via our Biomarker Academy™ training programs and post-approval services.


One of the largest commercial fleets of proteomics, genomics, and molecular pathology instruments –
all under one roof and laboratories on different continents to speed testing.


We routinely conduct concordance testing using our diverse, platform agnostic capabilities spanning the following technologies.    



Flow Cytometry

Molecular Pathology

Contact Us Today

Quick Links


Development and Clinical
Trial Solutions